Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-02-10 09:00:00
ExpreS2ion Biotech Holding AB ("ExpreS2ion") publishes an interview with the company's CEO Bent Frandsen, in which he sums up the company's achievements in 2021 and the outlook for the rest of 2021 and beyond. This includes discussing the status of the ABNCoV2 COVID-19 vaccine program and the recently in-licensed ES2B-C001 HER2 breast cancer vaccine project.
The CEO interview is available via this link: https://mailchi.mp/expres2ionbio.com/february2021
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
Telefon: +46 11 32 30 732
E-post: ca@skmg.se